Table 3 %CV analyzed by single and multiple linear regression analyses.

From: Enlarged glycemic variability in sulfonylurea-treated well-controlled type 2 diabetics identified using continuous glucose monitoring

  Univariable linear regression Multivariable linear regression
β SE P β SE P
Age − 0.052 0.045 0.253 − 0.063 0.054 0.244
Gender 1.23 1.306 0.348 0.948 1.26 0.453
BMI − 0.224 0.11 0.045* − 0.351 0.112 0.002*
HbA1c(NGSP) 0.171 0.418 0.684 − 0.327 0.423 0.442
eGFR 0.050 0.027 0.064 0.016 0.03 0.583
Micro-angiopathy 0.054 1.331 0.968 1.128 1.258 0.372
Macro-angiopathy 0.058 1.759 0.974 0.148 1.699 0.931
SU 2.886 1.272 0.025* 2.678 1.244 0.034*
TZD 1.456 1.72 0.399 0.815 1.616 0.615
BG 0.488 1.325 0.713 − 0.828 1.296 0.524
α-GI − 8.002 1.982  < 0.001* − 9.186 2.14  < 0.001*
Glinide − 5.823 5.105 0.256 − 1.076 5.162 0.835
DPP4 inhibitor − 2.021 1.318 0.128 − 3.763 1.325 0.005*
GLP1RA − 4.649 3.635 0.203 − 8.656 3.39 0.012*
SGLT2 inhibitor − 4.917 7.214 0.497 − 6.162 6.685 0.359
R2   0.320
  1. β regression coefficient, SE standard error.
  2. *p < 0.05.